Evolving Landscape of Immunotherapy in Melanoma
JCO Oncology Practice · 25.06.2026
DOI: 10.1200/op-25-01301 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, online erschienen am 25.06.2026. Verfasst von Alicia H Darwin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University School of Medicine, Stanford, CA. Die Arbeit nennt 167 Literaturangaben.
Abstract (Originalsprache)
Cutaneous melanoma management has been revolutionized by immunotherapy. Immune checkpoint inhibitors, first approved for melanoma in 2011, have become a mainstay in melanoma management. More recently, tumor infiltrating lymphocyte therapy has represented an exciting addition to our immunotherapeutic armamentarium against melanoma. Immunotherapy has improved relapse-free survival in patients with high-risk localized melanoma and overall survival in patients with metastatic disease to the order of years from historic prognoses of just months. Despite these advancements, not every patient benefits, highlighting the need for continued innovation and refinement of melanoma treatment. This review provides an overview of our approach to managing localized and metastatic melanoma, highlighting key data supporting our decision making. We also highlight ongoing trials poised to shape the future of melanoma care in the coming years.
Autor:innen und Institutionen
- Department of Medicine, Stanford University School of Medicine, Stanford, CA.
- Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
ORCID-Profile: Alicia H Darwin, James C Dickerson, Pauline Funchain
Zitieren
APA
Darwin, A. H., Dickerson, J. C., & Funchain, P. (2026). Evolving Landscape of Immunotherapy in Melanoma. JCO Oncology Practice. https://doi.org/10.1200/op-25-01301
Vancouver
Darwin AH, Dickerson JC, Funchain P. Evolving Landscape of Immunotherapy in Melanoma. JCO Oncology Practice. 2026. doi:10.1200/op-25-01301
BibTeX
@article{Darwin2026,
author = {Darwin, Alicia H and Dickerson, James C and Funchain, Pauline},
title = {Evolving Landscape of Immunotherapy in Melanoma},
journal = {JCO Oncology Practice},
year = {2026},
doi = {10.1200/op-25-01301}
}
EUVIMED